Letter: Levamisole (NSC-177023) in clinical immunotherapy
- PMID: 1260776
Item in Clipboard
Letter: Levamisole (NSC-177023) in clinical immunotherapy
Cancer Treat Rep.
1976 Mar.
No abstract available
Similar articles
-
[Levamisole--immunotherapy for everyone?].Ugeskr Laeger. 1977 Feb 28;139(9):517-20. Ugeskr Laeger. 1977. PMID: 320738 Clinical Trial. Danish. No abstract available.
-
Letter: Immunotherapy with levamisole.N Engl J Med. 1976 Feb 19;294(8):447. N Engl J Med. 1976. PMID: 1246321 No abstract available.
-
Chemo-immunotherapy with levamisole in metastatic breast carcinoma: a controlled clinical trial.Cancer Clin Trials. 1980 Spring;3(1):5-10. Cancer Clin Trials. 1980. PMID: 6993035 Clinical Trial.
-
[Adjuvant systemic chemo- or immunotherapy of colon cancer].Chirurg. 1994 Jun;65(6):503-8. Chirurg. 1994. PMID: 8088205 Review. German.
-
Surgical adjuvant immunotherapy for lung cancer: a review.Curr Surg. 1984 Jul-Aug;41(4):254-61. Curr Surg. 1984. PMID: 6383721 Review. No abstract available.
Cited by
-
Restoration of methotrexate-suppressed oxazolone-induced contact sensitivity with levamisole.Inflammation. 1978 Mar;3(1):111-6. doi: 10.1007/BF00917326. Inflammation. 1978. PMID: 680948
-
Condition-dependent immunoregulatory control of contact sensitivity by levamisole.Inflammation. 1977 Dec;2(4):277-84. doi: 10.1007/BF00921007. Inflammation. 1977. PMID: 617957
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources